At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Multi-centre, Double-blind, Randomised, Parallel Group Study to Assess the Efficacy and Safety of Multiple Doses of Topically Applied Hyperemisation-inducing Ointment (2cm Ointment Line Per Application; up to 3 Times Daily for up to 4 Days) Containing 2.5% Nicoboxil/0.4% Nonivamide Versus 2.5% Nicoboxil, 0.4% Nonivamide and Placebo in Patients 18 to 65 Years of Age With Acute Low Back Pain
In Brief
A Phase 3 clinical trial evaluating nicoboxil, placebo matching nonivamide + nicoboxil, and 2 other interventions for Acute Low Back Pain. Completed, enrolled 805 participants across 37 sites.
Detailed Summary
The aim of this study is to assess the efficacy and tolerability of Nicoboxil/Nonivamide ointment in comparison to Nicoboxil, Nonivamide, and placebo ointments for the treatment of acute low back pain.
Study Details
Timeline
Interventions
2cm ointment line for a skin area of approximately 20 cm x 20 cm up to 3 times in a 24h period
2cm ointment line for a skin area of approximately 20 cm x 20 cm up to 3 times in a 24h period
2cm ointment line for a skin area of approximately 20 cm x 20 cm up to 3 times in a 24h period
2cm ointment line for a skin area of approximately 20 cm x 20 cm up to 3 times in a 24h period